Critical Care

official impact factor 4.60

Email this article to a friend

Does tirofiban prevent platelet loss in patients after cardiogenic shock during continuous renal replacement therapy?

Christian Storm and Achim Jörres*

Critical Care 2008, 12:193 doi:10.1186/cc7083

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.